Turn Therapeutics Inc expected to post a loss of 3 cents a share - Earnings Preview
Turn Therapeutics Inc <TTRX.OQ> expected to post a loss of 3 cents a share - Earnings Preview
Turn Therapeutics Inc TTRX.OQ TTRX.O is expected to report resultson June 25 (estimated) for the period ending June 30 2026
LSEG's mean analyst estimate for Turn Therapeutics Inc is for a loss of 3 cents per share.
The one available analyst rating on the shares is "buy".
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Turn Therapeutics Inc is $6.15, about 6.6% above its last closing price of $5.77
This summary was machine generated June 23 at 11:01 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on Turn Therapeutics
See all newsTurn Therapeutics Q2 net loss per share widens on higher R&D costs
Turn Therapeutics Inc expected to post a loss of 3 cents a share - Earnings Preview
Turn Therapeutics Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Turn Therapeutics Reports Interim Analysis Findings And Adaptive Optimization Strategy From Phase 2 GX-03 Trial In Moderate-To-Severe Atopic Dermatitis
Brief: Turn Therapeutics Reports First Quarter 2026 Financial Results